NEO-CONCEPT INTL GROUP HLDNG (NCI)
KYG6421C1042 - Common Stock
We assign a fundamental rating of 1 out of 10 to NCI. NCI was compared to 49 industry peers in the Textiles, Apparel & Luxury Goods industry. NCI may be in some trouble as it scores bad on both profitability and health. NCI does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year NCI was profitable.
NCI had a negative operating cash flow in the past year.
1.2 Ratios
With a decent Return On Assets value of 4.87%, NCI is doing good in the industry, outperforming 68.75% of the companies in the same industry.
With an excellent Return On Invested Capital value of 34.28%, NCI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | N/A | ||
| ROIC | 34.28% |
ROA(3y)16.01%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NCI has a Profit Margin (2.53%) which is comparable to the rest of the industry.
Looking at the Operating Margin, with a value of 5.19%, NCI is in line with its industry, outperforming 47.92% of the companies in the same industry.
NCI's Gross Margin of 20.12% is on the low side compared to the rest of the industry. NCI is outperformed by 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.19% | ||
| PM (TTM) | 2.53% | ||
| GM | 20.12% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NCI is creating value.
NCI has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for NCI has been reduced compared to a year ago.
2.2 Solvency
NCI has an Altman-Z score of 1.89. This is not the best score and indicates that NCI is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.89, NCI is doing worse than 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.89 |
ROIC/WACC3.67
WACC9.33%
2.3 Liquidity
A Current Ratio of 0.91 indicates that NCI may have some problems paying its short term obligations.
With a Current ratio value of 0.91, NCI is not doing good in the industry: 95.83% of the companies in the same industry are doing better.
NCI has a Quick Ratio of 0.91. This is a bad value and indicates that NCI is not financially healthy enough and could expect problems in meeting its short term obligations.
NCI's Quick ratio of 0.84 is on the low side compared to the rest of the industry. NCI is outperformed by 79.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.91 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
The earnings per share for NCI have decreased strongly by -64.40% in the last year.
Looking at the last year, NCI shows a very negative growth in Revenue. The Revenue has decreased by -49.86% in the last year.
EPS 1Y (TTM)-64.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.4%
Revenue 1Y (TTM)-49.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-49.86%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 23.67, which indicates a rather expensive current valuation of NCI.
NCI's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.41, NCI is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.67 | ||
| Fwd PE | N/A |
4.2 Price Multiples
NCI's Enterprise Value to EBITDA is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.21 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NCI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NEO-CONCEPT INTL GROUP HLDNG
NASDAQ:NCI (1/3/2025, 8:00:01 PM)
After market: 0.71 0 (0%)0.71
+0.11 (+18.29%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners0.49%
Inst Owner Change0%
Ins Owners1.9%
Ins Owner Change0%
Market Cap14.68M
Analysts60
Price TargetN/A
Short Float %2.01%
Short Ratio0.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.67 | ||
| Fwd PE | N/A | ||
| P/S | 0.66 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.21 |
EPS(TTM)0.03
EY4.23%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS1.08
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | N/A | ||
| ROCE | 43.52% | ||
| ROIC | 34.28% | ||
| ROICexc | 47.7% | ||
| ROICexgc | 47.7% | ||
| OM | 5.19% | ||
| PM (TTM) | 2.53% | ||
| GM | 20.12% | ||
| FCFM | N/A |
ROA(3y)16.01%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.05%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.92
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 879.05% | ||
| Cap/Sales | 0.73% | ||
| Interest Coverage | 1.47 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.91 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 1.89 |
F-Score4
WACC9.33%
ROIC/WACC3.67
Cap/Depr(3y)318.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.26%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-49.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-49.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.12%
OCF growth 3YN/A
OCF growth 5YN/A